Applicant, as named in the Orange Book

Acadia Pharms Inc

Next listed expiry: Nuplazid on 23 Sep 2037. 4 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Nuplazid pimavanserin tartrate	pimavanserin tartrate	207318	23 Sep 2037	patent
Nuplazid pimavanserin tartrate	pimavanserin tartrate	210793	27 Feb 2039	patent
Daybue trofinetide	trofinetide	217026	12 Jan 2043	patent
Daybue Stix · 3 strengths trofinetide	trofinetide	219884	12 Jan 2043	patent